News

Michel Finance is appointed CEO. Executive team is strengthened with the appointment of: Daniele Zanotti (the former CEO) as Chief Technology and Innovation Officer leading technology developments and the execution [...]

Outstanding results from SCOPE 1 randomized, controlled, multicentric clinical trial, proving the efficacy of treating life-threatening Abdominal Aortic Aneurysm (AAA), by thrombogenic fibers embolization of the aneurysm sac when performing [...]

EUR 12 million financing comprising three tranches of EUR 4 million straight bonds. Clearing financial path to achieve major clinical milestones in view of regulatory approvals.

• Positive results from the first clinical study on 3 patients implanted between May and September 2018 • The implant technique, via laparoscopy and open surgery, was validated, surgical safety [...]